Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan.
J Bone Miner Res. 2011 May;26(5):1072-83. doi: 10.1002/jbmr.301.
Calcitonin (CT) is one of the hormones involved in vertebrate calcium regulation. It has been proposed to act as a hypocalcemic factor, but the regulatory pathways remain to be clarified. We investigated the CT/calcitonin gene-related peptide (CGRP) family in zebrafish and its potential involvement in calcium homeostasis. We identified the presence of four receptors: CTR, CRLR1, CRLR2, and CRLR3. From the phylogenetic analysis, together with the effect observed after CT and CGRP overexpression, we concluded that CTR appears to be a CT receptor and CRLR1 a CGRP receptor. The distribution of these two receptors shows a major presence in the central nervous system and in tissues involved in ionoregulation. Zebrafish embryos kept in high-Ca(2+)-concentration medium showed upregulation of CT and CTR expression and downregulation of the epithelial calcium channel (ECaC). Embryos injected with CT morpholino (CALC MO) incubated in high-Ca(2+) medium, showed downregulation of CTR together with upregulation on ECaC mRNA expression. In contrast, overexpression of CT cRNA induced the downregulation of ECaC mRNA synthesis, concomitant with the downregulation in the calcium content after 30 hours postfertilization. At 4 days postfertilization, CT cRNA injection induced upregulation of hypercalcemic factors, with subsequent increase in the calcium content. These results suggest that CT acts as a hypocalcemic factor in calcium regulation, probably through inhibition of ECaC synthesis.
降钙素(CT)是参与脊椎动物钙调节的激素之一。它被提议作为降血钙因子,但调节途径仍有待阐明。我们研究了斑马鱼中的 CT/降钙素基因相关肽(CGRP)家族及其在钙稳态中的潜在作用。我们鉴定出存在四种受体:CTR、CRLR1、CRLR2 和 CRLR3。从系统发育分析,以及 CT 和 CGRP 过表达后的作用观察,我们得出结论,CTR 似乎是 CT 受体,而 CRLR1 是 CGRP 受体。这两种受体的分布在中枢神经系统和参与离子调节的组织中存在主要表达。在高钙(Ca2+)浓度培养基中培养的斑马鱼胚胎表现出 CT 和 CTR 表达上调,上皮钙通道(ECaC)下调。在高 Ca2+介质中孵育的 CT 卵黄蛋白(CALC MO)注射的胚胎显示 CTR 下调,同时 ECaC mRNA 表达上调。相比之下,CT cRNA 的过表达诱导 ECaC mRNA 合成下调,同时在受精后 30 小时后钙含量下降。在受精后 4 天,CT cRNA 注射诱导高钙血症因子上调,随后钙含量增加。这些结果表明 CT 作为钙调节中的降血钙因子发挥作用,可能通过抑制 ECaC 合成。